Hossein Ameri, MD: Will CRISPR Fix Retinitis Pigmentosa? – MD Magazine
MD Magazine |
Hossein Ameri, MD: Will CRISPR Fix Retinitis Pigmentosa?
MD Magazine Thomas Castles. @Thomas_Castles. Currently, patients with retinitis pigmentosa (RP) are limited to receiving retinal prosthesis. It’s the only approved treatment for the condition, and is only suitable for patients with advanced disease and profound … |
|
Protagen Collaborating With UCSF on Prostate Cancer Immunotherapy Work
360Dx NEW YORK (360Dx) – Protagen said today it has entered a collaboration with the University of California, San Francisco to use the company’s SeroTag platform for research into immunotherapies for prostate cancer. The collaboration will use Protagen’s … Protagen AG Collaborates with UCSF to Study Better Immuno-Profiling of Cancer Patients Receiving ImmunotherapyFort Bend Herald |
Futurity: Research News |
Implanting stem cell ‘patch’ can restore vision
Futurity: Research News Researchers have developed a specially engineered retinal patch to treat people with sudden, severe sight loss. In July 2015, 86-year-old Douglas Waters developed severe age-related macular degeneration. He struggled to see things clearly, even when up … Suffering from severe osteoarthritis? Stem cell therapy can helpPalm Beach Post Stem Cell Therapy Market Fabricating opportunities 2025Technical Progress Hematopoietic Stem Cell Transplantation (HSCT) Sales market to grow at a CAGR of 10-15% till 2024Expert Consulting Information-Analytic Agency NEWS.am all 37 news articles » |
|
New CAR T case study shows promise in acute myeloid leukemia
EurekAlert (press release) Chimeric Antigen Receptor T–cell therapy, also known as CAR T therapy, was named the biggest research breakthrough of 2017 by the American Society of Clinical Oncology. The personal gene therapy utilizes a patient’s own immune cells to fight cancer … |
|
New CAR T case study shows promise in acute myeloid leukemia
EurekAlert (press release) Chimeric Antigen Receptor T–cell therapy, also known as CAR T therapy, was named the biggest research breakthrough of 2017 by the American Society of Clinical Oncology. The personal gene therapy utilizes a patient’s own immune cells to fight cancer … |
Immuno-Oncology News |
Researchers May Now Predict Which CLL Patients Will Respond to Kymriah CAR T-Cell Therapy, Study Says
Immuno-Oncology News This immuno-oncology treatment is developed using the patient’s own T-cells to target proteins located on the surface of cancer cells. Researchers from the Perelman School of Medicine at the University of Pennsylvania (Penn Medicine) and Novartis have … |
Immuno-Oncology News |
Researchers May Now Predict Which CLL Patients Will Respond to Kymriah CAR T-Cell Therapy, Study Says
Immuno-Oncology News This immuno-oncology treatment is developed using the patient’s own T-cells to target proteins located on the surface of cancer cells. Researchers from the Perelman School of Medicine at the University of Pennsylvania (Penn Medicine) and Novartis have … |